App-Quantinova.ai

How to manage asymptomatic carriers of antiphospholipid antibodies

L. Andreoli - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Hydroxychloroquine

Incidence of thromboembolic events in the tofacitinib rheumatoid arthritis, psoriasis, psoriatic arthritis and ulcerative colitis development programmes

P.J. Mease - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Methotrexate

Increased frequency of obstructive sleep apnea syndrome in behcet’s syndrome patients with vena cava superior thrombosis

A. Gokturk - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Low vitamin d is associated with thrombosis in systemic lupus erythematosus

M. Petri - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Pregnancy outcomes in women with antiphospholipid antibodies: interim results from a single centre cohort study

K. Schreiber - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Interferon-alpha for the management of lower extremity deep vein thrombosis in behcet’s syndrome: a case series

Y. Ozguler - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Interferon alpha

Pre-Operative Thromboprophylaxis Does Not Increase Bleeding Risk in Patients With Hip Fracture

Halli Krzyzaniak - Canadian Orthopaedic Association (COA|CORA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Heparin

Incidence of Symptomatic Venous Thromboembolism in Proximal Hamstring Repair: A Prospective Cohort Study

Ajay Asokan - American Orthopaedic Society for Sports Medicine (AOSSM) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Aspirin

Pyoderma gangrenosum: Ulcerative to pustular variety

Estefania Boland-Rodriguez - American Academy of Dermatology (AAD) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Prednisone

Non-Uremic Calciphylaxis Precipitated by COVID 19 Infection

Nate Messenger - American Academy of Dermatology (AAD) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

sodium thiosulfate

Serious adverse events associated with hormonal contraceptive use for acne treatment, based on reporting to the FDA Adverse Events Reporting Database

Elizabeth M Rao - American Academy of Dermatology (AAD) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

C-reactive protein levels and circulating blood inflammatory markers are associated with poor outcomes in Hidradenitis Suppurativa patients: A multi-center cohort study

Varsha Parthasarathy - American Academy of Dermatology (AAD) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

COVID-19 Outcomes Among Patients with Cutaneous T-cell Lymphoma: A Multicentered Analysis

Mairead Baker - American Academy of Dermatology (AAD) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

Polidocanol: A Review of Clinical Uses

Carly Stender - American Academy of Dermatology (AAD) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Asclera

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

Lea Hoisnard - American Academy of Dermatology (AAD) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Baricitinib

Diagnosing a rare but life-threatening disease: Catastrophic Antiphospholipid Syndrome

Moarij Qazi - National Kidney Foundation (NKF) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Hydroxychloroquine

Initial experience with thrombectomy of endoAVF created by WavelinQ System.

Sunil Sherchan - National Kidney Foundation (NKF) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Renal Vein Thrombosis in High-Grade Urothelial Carcinoma without Nephrotic Syndrome

Alka Tyagi - National Kidney Foundation (NKF) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Fatal complication of Focal Segmental Glomerulosclerosis and its Management Dilemma

Josue Ocasio Tapia - National Kidney Foundation (NKF) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Fibrinogen (IV)

Unique immune signatures predict potential cardiometabolic risk in severe COVID-19 patients and COVID-19 recovered individuals

Namal Liyanage - American Association of Immunologists (AAI) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

TIMP-2

Filters

7277 Abstracts